Document Detail


Longitudinal Assessment of Concurrent Changes in Left Ventricular Ejection Fraction and Left Ventricular Myocardial Tissue Characteristics After Administration of Cardiotoxic Chemotherapies Using T1-Weighted and T2-Weighted Cardiovascular Magnetic Resonance.
MedLine Citation:
PMID:  25273568     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: -In a murine anthracycline-related cardiotoxicity model, increases in cardiovascular magnetic resonance (CMR) myocardial contrast-enhanced T1-weighted signal intensity are associated with myocellular injury and decreases in left ventricular ejection fraction (LVEF). We sought to determine if T1- and T2-weighted measures of signal intensity associate with decreases in LVEF in human subjects receiving potentially cardiotoxic chemotherapy.
METHODS AND RESULTS: -In 65 individuals with breast cancer (n=51) or a hematologic malignancy (n=14), we measured left ventricular volumes, EF, and contrast-enhanced T1-weighted and T2-weighted signal intensity prior to and 3 months after initiating potentially cardiotoxic chemotherapy using blinded, unpaired analysis of CMR images. Participants were aged 51±12 years of whom 55% received an anthracycline, 38% received a monoclonal antibody, and 6% received an antimicrotubule agent. Overall, LVEF decreased from 57±6% to 54±7% (p<0.001) due to an increase in end-systolic volume (p<0.05). T1-weighted signal intensities also increased from 14.1±5.1 to 15.9±6.8 (p<0.05) with baseline values trending higher among individuals who received chemotherapy prior to study enrollment (p=0.06). Changes in T1-weighted signal intensity did not differ within the 17 LV myocardial segments (p=0.97). Myocardial edema quantified from T2-weighted images did not change significantly after 3 months (p=0.70).
CONCLUSIONS: -Concordant with previous animal studies, CMR measures of contrast-enhanced T1-weighted signal intensity occur commensurate with small but significant LVEF declines 3 months after receipt of potentially cardiotoxic chemotherapy. These data indicate that changes in T1-weighted signal intensity may serve as an early marker of subclinical injury related to the administration of potentially cardiotoxic chemotherapy in human subjects.
Authors:
Jennifer H Jordan; Ralph B D'Agostino; Craig A Hamilton; Sujethra Vasu; Michael E Hall; Dalane W Kitzman; Vinay Thohan; Julia A Lawrence; Leslie R Ellis; Timothy L Lash; W Gregory Hundley
Related Documents :
22222088 - Tricuspid valve replacement through a left atriotomy and transseptal approach in a cong...
8576778 - Multiple risk factors for coronary heart disease in patients with hypertension.
7397048 - Stopping smoking and long-term mortality after acute myocardial infarction.
22368568 - Double orifice mitral valve associated with ventricular septal defect in an infant: cas...
7677538 - Update on current techniques of myocardial protection.
10691178 - Simultaneous alterations of qrs configuration and tachycardia cycle length during radio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-1
Journal Detail:
Title:  Circulation. Cardiovascular imaging     Volume:  -     ISSN:  1942-0080     ISO Abbreviation:  Circ Cardiovasc Imaging     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-2     Completed Date:  -     Revised Date:  2014-10-3    
Medline Journal Info:
Nlm Unique ID:  101479935     Medline TA:  Circ Cardiovasc Imaging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic Deletion of LXR? Prevents Arsenic-Enhanced Atherosclerosis, But Not Arsenic-Altered Plaque C...
Next Document:  Myocardial Perfusion Imaging in Emergency Department Patients With Negative Cardiac Biomarkers: Yiel...